Hyper Corporation

Hyper Corporation Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Hyper Corporation (065650.KQ) as of Nov 5, 2026 is -4.15. In the previous year, Cash Conversion Cycle (CCC) was 64.19 — a change of -106.46% (lower).

Cash Conversion Cycle

-4.15

YoY

-106.46%

Last updated:

Cash Conversion Cycle (CCC) of Hyper Corporation is 2025 -4.15 . Cash Conversion Cycle (CCC) of Hyper Corporation was 2024 64.19 . It decreases by -106.46% lower compared to the previous year.

The Hyper Corporation Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
67.41 KRW
Jan 1, 2019
137.56 KRW
Jan 1, 2020
88.89 KRW
Jan 1, 2021
68.65 KRW
Jan 1, 2022
81.58 KRW
Jan 1, 2023
3.45 KRW
Jan 1, 2024
64.19 KRW
Jan 1, 2025
-4.15 KRW
The Hyper Corporation Cash Conversion Cycle history
YEARCash Conversion CycleYoY
-4.15-106.46%
64.19+1,759.51%
3.45-95.77%
81.58+18.83%
68.65-22.77%
88.89-35.38%
137.56+104.07%
67.41-8.45%
73.63-1.75%
74.94-33.24%
112.26-15.44%
132.75—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

Cash Conversion Cycle (CCC) of Hyper Corporation is -4.15 in 2025.

Cash Conversion Cycle (CCC) of Hyper Corporation changed from 64.19 to -4.15, representing a -106.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Hyper Corporation with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Hyper Corporation

All Key Metrics — Hyper Corporation